Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort pMDI with and without Aerochamber Plus in Asthma
NCT00915538Phase 4Completed
- Sponsor
- Western Sky Medical Research
- Start
- Jul 2009
- Primary completion
- Aug 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of budesonide + formoterol in asthma (2 arms), sponsored by Western Sky Medical Research. Primary endpoint: Mean Area Under the Curve (AUC) of Forced Expiratory Volume in One Second (FEV-1) Over 12 Hours at 720 months. Started Jul 2009; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00915538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915538.